Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LEG.DE
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Balanced
50%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 3.10 0.85 0.83
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 792.81 103.23 -11.56
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.83 101.54 100.71
Cash 3.60 3.85 3.71
Capex 67.74 -0.03 -0.08
Free Cash Flow -1.93 1.79 1.82
Revenue 7.99 4.42 4.09
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -28.97 0.31 0.43
Operating Margin -90.24 0.26 -2.63
ROA -90.48 < 0.005 -0.03
ROE -90.50 < 0.005 -0.08
ROIC -89.68 < 0.005 -0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LEG.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LEG.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LEG.DE is permitted for members.